Clinical Trials Logo

Disease clinical trials

View clinical trials related to Disease.

Filter by:

NCT ID: NCT00282165 Terminated - Psychotic Disorders Clinical Trials

Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order

Start date: November 2006
Phase: Phase 4
Study type: Interventional

In a double blind randomized clinical trial with cross-over design, treatment using naratriptan will be compared to placebo within a group of 30 convicts with psychiatric disorders such as psychosis or psychopathy with repeated aggressive outbursts resistant to conventional psychopharmacologic and other psychotherapeutic treatment. Hypothesis is that addition of naratriptan to the individual treatment regime reduces aggression -and improves general outcome- as compared to addition of placebo and is well tolerated in this group and under these conditions.

NCT ID: NCT00257894 Terminated - Smoking Clinical Trials

Baclofen Effects on Smoking Urge and Withdrawal

Start date: December 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether baclofen is effective in reducing smoking urge, withdrawal, and reinforcement in moderate to heavy cigarette smokers.

NCT ID: NCT00250055 Terminated - Cancer Clinical Trials

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

Start date: April 2004
Phase: N/A
Study type: Interventional

In general, to determine the sensitivity of light transport to tissue from morphological features of clinical significance. Determine how specific structural features contribute to light scattering. Investigate light scattering differences in tumorigenic and nontumorigenic cells. Develop and implement quantitative and sensitive methods for measuring morphological properties. Clinical measurements.

NCT ID: NCT00226824 Terminated - Tourette's Syndrome Clinical Trials

Safety Study of Galantamine in Tic Disorders

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions, etc.) will also be examined.

NCT ID: NCT00206765 Terminated - Panic Disorder Clinical Trials

Risperidone vs. Paroxetine for Panic Attacks

Start date: January 2003
Phase: Phase 2
Study type: Interventional

We are comparing the efficacy of Risperidone versus Paroxetine in the treatment of panic symptoms. The study hypothesis is that Risperidone will be a superior medicine for treating panic.

NCT ID: NCT00202449 Terminated - Clinical trials for Stress Disorders, Post-Traumatic

Prazosin vs Paroxetine in Combat Stress-Related Post-Traumatic Stress Disorder (PTSD) Nightmares & Sleep Disturbance

Start date: July 2004
Phase: N/A
Study type: Interventional

The purposes of this study are: - to evaluate the efficacy and tolerability of the drug prazosin compared to placebo for combat stress-related nightmares, sleep disturbance and overall function in recently combat-exposed returnees from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF). - to evaluate the effects of the selective serotonin reuptake inhibitor (SSRI) paroxetine on behavioral symptoms and overall function in this population.

NCT ID: NCT00183612 Terminated - Bipolar Disorder Clinical Trials

Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents

Start date: May 2000
Phase: N/A
Study type: Interventional

This study will examine the safety and effectiveness of the antipsychotic drug olanzapine in children and adolescents with bipolar disorder or psychosis.

NCT ID: NCT00183430 Terminated - Clinical trials for Post-Traumatic Stress Disorder

Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder

Start date: October 2003
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of prazosin in treating post-traumatic stress disorder caused by noncombat trauma in individuals taking selective serotonin reuptake inhibitors.

NCT ID: NCT00182533 Terminated - Clinical trials for Major Depressive Disorder

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

Start date: July 2002
Phase: Phase 4
Study type: Interventional

Selective serotonin reuptake inhibitors (SSRIs) including sertraline have been found to be effective in the treatment of generalized social phobia (GSP). However, virtually all of the current treatment studies with medicines, including the SSRIs, have excluded patients with social phobia who have other co-occurring conditions. In fact, 80% of individuals suffering with primary social phobia have at least one other anxiety. This study will evaluate the safety and efficacy of sertraline in the treatment of generalized social phobia with co-occurring anxiety and mood disorders.

NCT ID: NCT00176826 Terminated - Clinical trials for Hematologic Diseases

T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

Start date: September 2000
Phase: Phase 2/Phase 3
Study type: Interventional

The hypothesis is to determine if a preparative regimen of busulfan, cyclophosphamide, and antithymocyte globulin (ATG) plus allogeneic stem cell transplantation will be effective in the treatment of immune deficiencies and histiocytic disorders.